National Neuroscience Institute
Clinical trials sponsored by National Neuroscience Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental drug ACT001 targets tough brain tumors in small trial Results expected May 2027 (estimated)
-
Experimental drug ACT001 targets tough brain tumors in small trial
Disease control Recruiting nowThis phase 2 trial is testing an oral drug called ACT001 in 12 adults whose glioblastoma has returned after standard treatment. The study focuses on patients whose tumors have a specific genetic signature (STAT3-high). Researchers will check if the drug can shrink or stabilize th…
Phase 2 • Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Spinal stimulation trial aims to restore movement in paralyzed patients
Disease control Recruiting nowThis study is for adults over 21 with chronic spinal cord injury (more than a year) who have lost motor function. Researchers will implant a spinal cord stimulator and combine it with advanced robotic rehabilitation to see if it can improve movement, like walking. The main goal i…
Sponsor: National Neuroscience Institute • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC